We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $412M
1-Year Est. Return 18.33%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$1.14B
AUM Growth
-$103M
Cap. Flow
-$165M
Cap. Flow %
-14.39%
Top 10 Hldgs %
27.95%
Holding
409
New
33
Increased
123
Reduced
197
Closed
35

Top Buys

Rank Stock Value
1
DECK icon
Deckers Outdoor
DECK
+$9.69M
2
CFLT
Confluent
CFLT
+$4.33M
3
EDU icon
New Oriental
EDU
+$3.77M
4
MKTX icon
MarketAxess Holdings
MKTX
+$3.71M
5
PGR icon
Progressive
PGR
+$3.71M

Sector Composition

Rank Sector Weight
1 Healthcare 36.2%
2 Consumer Staples 24.24%
3 Technology 9.05%
4 Communication Services 8.78%
5 Financials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
1
AbbVie
ABBV
$453B
$33.9M 2.96%
218,747
-26,904
-11% -$3.92M
MRK icon
2
Merck
MRK
$371B
$33.6M 2.94%
307,928
-47,419
-13% -$4.92M
LLY icon
3
Eli Lilly
LLY
$1.02T
$33.2M 2.9%
56,906
-1,635
-3% -$954K
K
4
DELISTED
Kellanova
K
$32.5M 2.84%
581,722
-55,808
-9% -$2.92M
GIS icon
5
General Mills
GIS
$20.5B
$32.3M 2.82%
495,601
-67,115
-12% -$4.33M
JNJ icon
6
Johnson & Johnson
JNJ
$663B
$32.2M 2.82%
205,588
-27,726
-12% -$4.25M
CLX icon
7
Clorox
CLX
$11.3B
$31.6M 2.76%
221,333
-44,057
-17% -$5.87M
SJM icon
8
J.M. Smucker
SJM
$13.5B
$31.4M 2.75%
248,636
+18,279
+8% +$2.12M
NBIX icon
9
Neurocrine Biosciences
NBIX
$15.8B
$29.9M 2.61%
226,841
-70,343
-24% -$8.1M
NEM icon
10
Newmont
NEM
$135B
$29.1M 2.54%
703,013
-158,535
-18% -$6.12M
MCK icon
11
McKesson
MCK
$106B
$28.9M 2.52%
62,324
+2,645
+4% +$1.2M
CHD icon
12
Church & Dwight Co
CHD
$23.4B
$28.6M 2.51%
302,983
-12,151
-4% -$1.11M
T icon
13
AT&T
T
$176B
$28.5M 2.49%
1,699,322
+199,140
+13% +$3.14M
HUM icon
14
Humana
HUM
$48.2B
$28M 2.45%
61,123
-691
-1% -$341K
BMY icon
15
Bristol-Myers Squibb
BMY
$136B
$27.3M 2.39%
531,904
-44,446
-8% -$2.33M
KR icon
16
Kroger
KR
$35.9B
$26.3M 2.3%
575,413
-78,190
-12% -$3.47M
PFE icon
17
Pfizer
PFE
$162B
$25.6M 2.24%
889,327
-60,518
-6% -$1.83M
UTHR icon
18
United Therapeutics
UTHR
$20.9B
$25M 2.19%
113,757
-31,663
-22% -$7.3M
CPB icon
19
Campbell Soup
CPB
$6.38B
$23.2M 2.03%
537,090
-101,449
-16% -$4.17M
CBOE icon
20
Cboe Global Markets
CBOE
$31.2B
$21.7M 1.9%
121,582
-3,788
-3% -$649K
SLB icon
21
SLB Ltd
SLB
$85.3B
$20.9M 1.83%
401,281
+23,082
+6% +$1.25M
ANET icon
22
Arista Networks
ANET
$244B
$20.8M 1.82%
353,132
-64,948
-16% -$3.41M
VZ icon
23
Verizon
VZ
$208B
$20.3M 1.77%
537,953
-20,973
-4% -$742K
HSY icon
24
Hershey
HSY
$34.8B
$19M 1.66%
101,887
-8,686
-8% -$1.65M
FSLR icon
25
First Solar
FSLR
$22B
$18.9M 1.65%
109,493
-18,057
-14% -$2.76M

Similar funds

TOBAM's Q4 2023 Portfolio in Review

As of Q4 2023, TOBAM held 409 positions worth $1.14B, down 8.2% from $1.25B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

TOBAM withdrew a net $165M in Q4 2023, closing 35 positions and reducing 197 holdings. Its most notable exit was EQT Corp, an estimated $4.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 37% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, TOBAM opened a new position in Deckers Outdoor worth $10.6M.

  • TOBAM's largest Q4 2023 buy was Deckers Outdoor: 95,364 shares worth $10.6M.
  • TOBAM added most to MarketAxess Holdings in Q4 2023, an estimated $3.71M increase.
  • TOBAM's biggest Q4 2023 reduction was Gen Digital, cutting an estimated $10.5M.
  • TOBAM fully exited EQT Corp in Q4 2023, selling an estimated $4.3M.
  • TOBAM's ten largest holdings make up 28% of its $1.14B portfolio in Q4 2023.
  • TOBAM opened 33 new positions and closed 35 in Q4 2023.
  • TOBAM's portfolio value fell 8.2% quarter-over-quarter to $1.14B.

Based on TOBAM's 13F filing for Q4 2023, filed 26 Jan 2024.